echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The State Food and Drug Administration notified the clinical trial of Hilite Biotechnology to have a cause-based inspection

    The State Food and Drug Administration notified the clinical trial of Hilite Biotechnology to have a cause-based inspection

    • Last Update: 2022-01-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On December 29, 2021, the State Food and Drug Administration issued a notice on the inspection of clinical trials of Guangzhou Hilite Biotechnology Co.
    , Ltd.
    (2021 No.
    106)
    .
    The announcement shows that the State Food and Drug Administration organized a cause-based inspection of the clinical trial of the in vitro diagnostic reagent product accepted by Guangzhou Hilite Biotechnology Co.
    , Ltd.
    with the acceptance number CSZ1800101.
    The test data cannot be traced to the source
    .
    According to Article 78 of "Administrative Licensing Law of the People's Republic of China" and Article 49 of "Administrative Measures for the Registration of In Vitro Diagnostic Reagents", the registration application project will not be registered, and will not be registered within one year from the date of denial of registration.
    The application for registration of the project will be accepted again
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.